- Home
- WRD vs KNSA Comparison
WRD vs KNSA Comparison
Compare WRD & KNSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WRD
- KNSA
- Stock Information
- Founded
- WRD 2017
- KNSA 2015
- Country
- WRD China
- KNSA United Kingdom
- Employees
- WRD N/A
- KNSA N/A
- Industry
- WRD
- KNSA Biotechnology: Pharmaceutical Preparations
- Sector
- WRD
- KNSA Health Care
- Exchange
- WRD NYSE
- KNSA Nasdaq
- Market Cap
- WRD 2.0B
- KNSA 2.0B
- IPO Year
- WRD 2024
- KNSA 2018
- Fundamental
- Price
- WRD $8.01
- KNSA $26.03
- Analyst Decision
- WRD Buy
- KNSA Strong Buy
- Analyst Count
- WRD 2
- KNSA 6
- Target Price
- WRD $22.00
- KNSA $38.00
- AVG Volume (30 Days)
- WRD 11.3M
- KNSA 688.0K
- Earning Date
- WRD 05-21-2025
- KNSA 04-29-2025
- Dividend Yield
- WRD N/A
- KNSA N/A
- EPS Growth
- WRD N/A
- KNSA N/A
- EPS
- WRD N/A
- KNSA N/A
- Revenue
- WRD $49,476,511.00
- KNSA $481,166,000.00
- Revenue This Year
- WRD N/A
- KNSA $37.21
- Revenue Next Year
- WRD $194.65
- KNSA $1.53
- P/E Ratio
- WRD N/A
- KNSA N/A
- Revenue Growth
- WRD N/A
- KNSA 59.45
- 52 Week Low
- WRD $6.03
- KNSA $17.38
- 52 Week High
- WRD $44.00
- KNSA $28.56
- Technical
- Relative Strength Index (RSI)
- WRD N/A
- KNSA 63.21
- Support Level
- WRD N/A
- KNSA $25.97
- Resistance Level
- WRD N/A
- KNSA $28.56
- Average True Range (ATR)
- WRD 0.00
- KNSA 1.24
- MACD
- WRD 0.00
- KNSA 0.36
- Stochastic Oscillator
- WRD 0.00
- KNSA 71.70
About WRD WERIDE INC. SPON ADS EACH REP 3 CL A ORD SHS
WeRide Inc operates in the autonomous driving industry. The company has developed a universal autonomous driving technology platform that integrates full-stack software algorithms, modularized hardware solutions, and a cloud-based infrastructure platform. The company provides autonomous driving products and services from L2 to L4 vehicles. The products of the company includes Robotaxi, Robobus, Robovan, Robosweeper, and others. The company earns its revenue from the People's Republic of China.
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.